Interferon-alpha gel reduces recurrence in nasal inverted papilloma patients compared to surgery alone
This randomized controlled trial included 42 newly diagnosed nasal inverted papilloma patients. The intervention involved local application of interferon-alpha gel during and after surgery. The comparator group received endoscopic tumor resection without interferon-alpha gel. Follow-up lasted 12.0 months.
The primary outcome measured DIP endoscopic scoring system results at 3, 6, and 12 months. Positive expression rates of HPV6/11 in NIP tissues were 52.38% (22/42) in the study population. This rate was higher than the nasal polyp control group at 8.33% (1/12) with a p-value <0.05.
DIP scores between the interferon treatment group and control group showed no statistically significant differences (p > 0.05). Safety data were not reported for adverse events, serious adverse events, discontinuations, or tolerability. The study limitations were not reported. Funding or conflicts of interest were not reported.
Practice relevance was not reported. The evidence is limited by the small sample size of 42 patients and the lack of reported safety data. Clinicians should interpret these findings cautiously given the absence of significant differences in recurrence scores.